World Post Reporter
SEE OTHER BRANDS

Your global issues news reporter

World Post Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Post Reporter.

Press releases published on April 2, 2025

CTR Investments & Consulting Inc. Completes Acquisition of Shibue Couture, Inc.

CTR Investments & Consulting Inc. Completes Acquisition of Shibue Couture, Inc.

PALM DESERT, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- CTR Investments …

Marex Completes Acquisition of Aarna Capital as it Expands in the Middle East

Marex Completes Acquisition of Aarna Capital as it Expands in the Middle East

LONDON, April 02, 2025 (GLOBE NEWSWIRE) -- Marex Group plc, the diversified global financial services platform, today announces the completion of its acquisition of Aarna Capital Limited (“Aarna Capital”) expanding its operations in the Middle East and …

PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share

PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share

MIAMI, April 02, 2025 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) declares its monthly distribution for April 2025 of $0.1025 per share, payable on May 1, 2025 to stockholders of record as of April 15, 2025. The …

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2025 on Wednesday, April 23, 2025, after the New York Stock Exchange …

Duluth Holdings Inc. Announces Stephanie Pugliese as President and CEO

Duluth Holdings Inc. Announces Stephanie Pugliese as President and CEO

MOUNT HOREB, Wis., April 02, 2025 (GLOBE NEWSWIRE) -- Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading” or the “Company”) (NASDAQ: DLTH), a lifestyle brand of men’s and women’s workwear, casual wear, outdoor apparel, and accessories, …

Brookfield Renewable to Host First Quarter 2025 Results Conference Call

Brookfield Renewable to Host First Quarter 2025 Results Conference Call

BROOKFIELD, News, April 02, 2025 (GLOBE NEWSWIRE) -- Brookfield Renewable (NYSE: BEP, BEPC; TSX: BEP.UN, BEPC) (“Brookfield Renewable”) will hold its First Quarter 2025 Conference Call and Webcast on Friday, May 2, 2025 at 9:00 a.m. ET to discuss results …

GigaCloud Technology Inc Increases Share Repurchase Program by $16 Million

GigaCloud Technology Inc Increases Share Repurchase Program by $16 Million

EL MONTE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced that on March 28, …

Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028

Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028

PLANO, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior …

Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors

Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors

WEST CHESTER, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the …

FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference

FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference

SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending the 24th Annual Needham Virtual Healthcare Conference taking place April 7-10, 2025. FibroGen’s management team will be …

Safe Bulkers, Inc. Declares Quarterly Dividend on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares; 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares

Safe Bulkers, Inc. Declares Quarterly Dividend on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares; 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares

MONACO, April 02, 2025 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that the Company’s Board of Directors has declared: a cash dividend of $0.50 per …

Brookfield Infrastructure to Host First Quarter 2025 Results Conference Call

Brookfield Infrastructure to Host First Quarter 2025 Results Conference Call

BROOKFIELD, NEWS, April 02, 2025 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Partners will hold its first quarter 2025 conference call and webcast on Wednesday, April 30, 2025 at 9:00 a.m. (ET). Results will be released that morning before 7:00 a.m. (ET) …

BBSI Announces Appointment of Thomas McGinn as Senior Vice President of Insurance

BBSI Announces Appointment of Thomas McGinn as Senior Vice President of Insurance

VANCOUVER, Wash., April 02, 2025 (GLOBE NEWSWIRE) -- Barrett Business Services, Inc. (BBSI) (NASDAQ: BBSI), a leading provider of business management solutions, today announced the appointment of Thomas McGinn as Senior Vice President of Insurance. In this …

Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the …

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted eight newly-hired employees options to purchase …

GRI Bio Announces Closing of $5.0 Million Public Offering

GRI Bio Announces Closing of $5.0 Million Public Offering

LA JOLLA, CA, April 02, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and …

Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update

Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update

BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced fourth quarter financial …

eXoZymes Provides Fourth Quarter and Full Year 2024 Update

eXoZymes Provides Fourth Quarter and Full Year 2024 Update

Management to Host Conference Call Today at 4:30PM Eastern Monrovia, CA, April 02, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential …

NeuroPace Announces Refocusing of Product Portfolio

NeuroPace Announces Refocusing of Product Portfolio

-- Beginning of Wind Down of Stereo EEG (SEEG) Distribution Relationship in Q4 2025 -- -- Maintaining 2025 Revenue Guidance -- -- No Change to Long-Range Plan Expectations of Cash Flow Breakeven by the end of 2027 and Achievement of 20%+ Revenue CAGR -- …

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service